Top Page
Datametrex AI
(DM)
Datametrex AI (DM) vs. iShares MSCI Canada ETF (EWC)
Datametrex AI Business Overview & Revenue Model
Datametrex AI Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.82M | 6.49M | 7.80M | 30.49M | 49.03M | 12.38M |
| Gross Profit | 634.64K | 3.07M | 2.17M | 10.20M | 21.03M | 2.99M |
| EBITDA | -1.42M | -1.24M | -6.95M | -13.46M | 13.29M | -3.60M |
| Net Income | -2.98M | -3.06M | -19.14M | -17.26M | 9.09M | -5.01M |
Balance Sheet | ||||||
| Total Assets | 8.48M | 4.99M | 12.71M | 36.00M | 42.64M | 10.00M |
| Cash, Cash Equivalents and Short-Term Investments | 312.44K | 427.11K | 1.13M | 9.41M | 17.99M | 1.97M |
| Total Debt | 4.79M | 1.84M | 5.19M | 4.53M | 253.77K | 518.58K |
| Total Liabilities | 8.05M | 4.33M | 11.70M | 13.23M | 10.15M | 6.75M |
| Stockholders Equity | 430.64K | 656.40K | 1.00M | 22.77M | 32.49M | 3.25M |
Cash Flow | ||||||
| Free Cash Flow | -756.28K | -1.57M | -6.94M | -2.28M | 11.42M | -611.50K |
| Operating Cash Flow | -756.28K | -1.22M | -5.62M | -249.09K | 11.45M | -595.10K |
| Investing Cash Flow | 35.98K | 59.10K | -969.15K | -3.79M | -234.41K | -14.93K |
| Financing Cash Flow | 772.05K | 1.21M | -254.18K | -2.40M | 2.19M | 2.48M |
Datametrex AI Technical Analysis
Datametrex AI Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | C$44.42M | 2.41 | 39.00% | ― | 37.95% | ― | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
49 Neutral | $169.26M | -6.31 | -16.17% | ― | 3.40% | -691.81% | |
44 Neutral | C$104.58M | -3,571.43 | -0.42% | ― | -59.23% | -100.34% | |
41 Neutral | C$7.73M | -0.79 | -58.58% | ― | -56.02% | 91.71% | |
41 Neutral | C$5.17M | -5.43 | -3428.85% | ― | -15.33% | 47.13% | |
40 Underperform | C$8.31M | -0.12 | ― | ― | -18.97% | -55.19% |
Datametrex AI Corporate Events
Datametrex AI Limited has secured new purchase orders worth approximately CAD $400,000 through its wholly owned subsidiary, Datametrex Korea, reinforcing its role as a provider of IT infrastructure and technology solutions to large global enterprises. The contracts, expected to generate about CAD $400,000 in revenue at an estimated 17.5% profit margin, support the company’s global growth strategy and highlight the importance of its Korean operations in driving revenue growth, client expansion, and its broader ‘land and expand’ approach to building long-term, scalable technology service relationships.
The most recent analyst rating on (TSE:DM) stock is a Hold with a C$0.08 price target. To see the full list of analyst forecasts on Datametrex AI stock, see the TSE:DM Stock Forecast page.
Datametrex AI’s subsidiary Paymetrex has signed a technology licensing agreement with U.S.-based payments orchestration firm AnywhereCommerce, gaining access to its suite of payment products and services to bolster Paymetrex’s YuzuPay-branded platform. By combining AnywhereCommerce’s hardware and software with Paymetrex’s proprietary IP and expanding patent portfolio, the partners aim to deliver a broad range of payment solutions, including traditional card and debit processing as well as crypto and crypto-to-cash settlement, while targeting high-value merchant segments such as art, jewelry, automotive and luxury rentals; this collaboration is expected to enhance Paymetrex’s market differentiation, strengthen its technology infrastructure, and position it to benefit from the high-growth global cryptocurrency payments market.
The most recent analyst rating on (TSE:DM) stock is a Hold with a C$0.08 price target. To see the full list of analyst forecasts on Datametrex AI stock, see the TSE:DM Stock Forecast page.
Datametrex AI has closed its acquisition of the Yuzu payment processing solution, including associated patents and intellectual property, from Canadian fintech firm Firstpayment Inc. for $5.5 million, paid in 55 million Datametrex shares. The deal, executed through subsidiary Paymetrex, strengthens Datametrex’s push into advanced digital and cryptocurrency payment technologies and is expected to support the integration of Yuzu into its technology division and the pursuit of new merchant relationships to drive revenue, without changing the company’s core business or control structure. As part of the transaction, Firstpayment founder Michael Kron has joined Datametrex’s board and will serve as Vice President of Paymetrex, and now holds approximately 12.15% of Datametrex’s outstanding common shares, triggering early warning disclosure requirements under Canadian securities rules.
The most recent analyst rating on (TSE:DM) stock is a Hold with a C$0.10 price target. To see the full list of analyst forecasts on Datametrex AI stock, see the TSE:DM Stock Forecast page.
Datametrex AI Limited has signed a definitive agreement to acquire the Yuzu payment processing solution from Firstpayment Inc., a Canadian fintech company. This acquisition, valued at $5.5 million, will be paid through the issuance of 55 million common shares of Datametrex. The integration of Yuzu into Datametrex’s technology division is expected to enhance its operations and open up new merchant opportunities, with the transaction set to complete around December 17, 2025, pending customary approvals.
The most recent analyst rating on (TSE:DM) stock is a Hold with a C$0.10 price target. To see the full list of analyst forecasts on Datametrex AI stock, see the TSE:DM Stock Forecast page.
Datametrex AI Limited has announced the introduction of walk-in services at its Imagine Health Medical Clinics in Calgary and Edmonton, enhancing access to same-day medical care for urgent non-emergency needs. This expansion reflects the company’s commitment to improving healthcare accessibility and patient-focused care across Western Canada, with plans to further broaden its clinic network and service offerings.
The most recent analyst rating on (TSE:DM) stock is a Hold with a C$0.10 price target. To see the full list of analyst forecasts on Datametrex AI stock, see the TSE:DM Stock Forecast page.
Datametrex AI Limited has secured purchase orders worth approximately CAD $650,000 through its subsidiary, Datametrex Korea, marking a significant advancement in its expansion strategy. This achievement underscores the company’s role as a trusted IT infrastructure solutions provider and highlights its commitment to delivering exceptional value to global partners, reinforcing its presence in key international markets.
Datametrex AI Limited’s subsidiary, Imagine Health Medical Clinics, has expanded its team by adding four new physicians across its Calgary and Edmonton locations, enhancing its capacity to offer a broad spectrum of insured medical services. This strategic move aligns with the company’s objective to expand its healthcare division, ensuring high-quality, timely medical care for patients and supporting the growth of its healthcare services in these communities.
Datametrex AI Limited’s subsidiary, Imagine Health Medical Clinics Ltd., has relocated its Edmonton South clinic to a modern facility, enhancing its ability to provide high-quality, patient-focused care. This move aligns with Imagine Health’s mission to meet the evolving healthcare needs of the community, offering a comprehensive range of services including family medicine and specialized medical care.
Datametrex AI Limited announced the relocation of its subsidiary, Imagine Health Medical Clinics, to a new location in Calgary’s Capitol Hill area. This move aims to enhance patient care and accessibility, reflecting the company’s commitment to providing high-quality healthcare services. The new facility is fully operational and accepting new patients, indicating a strategic expansion in the Calgary community.
Datametrex AI Limited has announced the relocation of its subsidiary, Imagine Health Medical Clinics, to a new facility in Calgary’s Capitol Hill. This move aims to enhance patient care and accessibility, reflecting the company’s commitment to providing high-quality healthcare services. The new clinic is fully operational and accepting new patients, further solidifying Imagine Health’s presence in Calgary and its dedication to meeting the community’s healthcare needs.
Datametrex AI Limited has successfully closed its non-brokered private placement and subscription receipt financing, raising a total of $5,133,500. The funds will be used to integrate the Yuzu Payment Solution into its technology division and support business expansion, including the establishment of a new clinic. The completion of the subscription receipt financing is crucial for the acquisition of Yuzu Payment Solution, with specific conditions set for the release of funds from escrow.
Datametrex AI Limited has announced the closing date for its non-brokered private placement and subscription receipt financing, set for November 14, 2025. The company aims to raise up to $5.3 million to support business expansion, the integration of Yuzu Payment Solution, and general working capital, potentially impacting its market positioning and operational capabilities.
Datametrex AI Limited has appointed Mr. Enrico Moretti, a securities lawyer with extensive cross-border legal expertise, to its Board of Directors to fulfill the minimum director requirement under Exchange policies. This appointment aims to strengthen the company’s governance and compliance framework, as the company works diligently to address a trading halt imposed by the Exchange due to the previous deficiency in board composition. Mr. Moretti’s expertise is expected to be a valuable asset in enhancing the company’s corporate governance and regulatory compliance.